INNOVENT BIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
INNOVENT BIO: LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
INNOVENT BIO: CHANGE IN COMPOSITION OF BOARD COMMITTEES
INNOVENT BIO: GRANT OF SHARE OPTIONS AND RESTRICTED SHARES
INNOVENT BIO: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED 30 JUNE 2024
INNOVENT BIO: VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION APPROVED CHINA'S FIRST KRAS G12C INHIBITOR DUPERT
INNOVENT BIO: DATE OF BOARD MEETING
INNOVENT BIO: INSIDE INFORMATION ANNOUNCEMENT - UPDATE ON THE COMPANY'S PRODUCT REVENUE IN THESECOND QUARTER OF 2024
INNOVENT BIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
INNOVENT BIO: VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATIONACCEPTED THE NEW DRUG APPLICATION OF MAZDUTIDEFOR TYPE 2 DIABETES
INNOVENT BIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
INNOVENT BIO: POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON JUNE 21, 2024
INNOVENT BIO: Amended and Restated Memorandum and Articles of Association
INNOVENT BIO: POLL RESULTS OF THE ANNUAL GENERAL MEETINGHELD ON JUNE 21, 2024
INNOVENT BIO: GRANT OF SHARE OPTIONS AND GRANT OF RESTRICTED SHARES
INNOVENT BIO: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
INNOVENT BIO: Form of Proxy for use at the Extraordinary General Meeting to be held onFriday, June 21, 2024
INNOVENT BIO: NOTICE OF EXTRAORDINARY GENERAL MEETING
INNOVENT BIO: (1) PROPOSED GRANTS OF RESTRICTED SHARES TO DIRECTORSUNDER THE 2020 RS PLAN,(2) PROPOSED ADOPTION OF THE 2024 SHARE SCHEME, AND(3) NOTICE OF EXTRAORDINARY GENERAL MEETING
INNOVENT BIO: Form of Proxy for use at the Annual General Meeting to be held onFriday, June 21, 2024
No Data